Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence

Tropical Medicine and International Health - Tập 6 Số 11 - Trang 864-873 - 2001
Thomas Smith1, Amadou Ibrahima Mbaye1,2, Sake J. de Vlas3, Foekje F. Stelma4, F. Guissé4,2, Lisette van Lieshout4, Denis Bourgeois2, Mouhamadou Diop2, Ann Ly2, Louis Albert Tchuem-Tchuenté1, Dirk Engels1,5, Katja Polman1
1Institute of Tropical Medicine, Antwerp, Belgium
2Région Médicale de St Louis, Senegal
3Department of Public Health, Erasmus University Rotterdam, Rotterdam, The Netherlands
4Department of Parasitology, University of Leiden, Leiden, The Netherlands
5World Health Organization, Geneva, Switzerland

Tóm tắt

This paper summarizes and concludes in‐depth field investigations on suspected resistance of Schistosoma mansoni to praziquantel in northern Senegal. Praziquantel at 40 mg/kg usually cures 70–90% of S. mansoni infections. In an initial trial in an epidemic S. mansoni focus in northern Senegal, only 18% of the cases became parasitologically negative 12 weeks after treatment, although the reduction in mean egg counts was within normal ranges (86%). Among other hypotheses to explain the observed low cure rate in this focus, the possibility of drug resistance or tolerance had to be considered. Subsequent field trials with a shorter follow‐up period (6–8 weeks) yielded cure rates of 31–36%. Increasing the dose to 2 × 30 mg/kg did not significantly improve cure rates, whereas treatment with oxamniquine at 20 mg/kg resulted in a normal cure rate of 79%. The efficacy of praziquantel in this focus could be related to age and pre‐treatment intensity but not to other host factors, including immune profiles and water contact patterns. Treatment with praziquantel of individuals from the area residing temporarily in an urban region with no transmission, and re‐treatment after 3 weeks of non‐cured individuals within the area resulted in normal cure rates (78–88%). The application of an epidemiological model taking into account the relation between egg counts and actual worm numbers indicated that the low cure rates in this Senegalese focus could be explained by assuming a 90% worm reduction after treatment with praziquantel; in average endemic situations, such a drug efficacy would result in normal cure rates. Laboratory studies by others on the presence or absence of praziquantel resistance in Senegalese schistosome strains have so far been inconclusive. We conclude that there is no convincing evidence for praziquantel‐resistant S. mansoni in Senegal, and that the low cure rates can be attributed to high initial worm loads and intense transmission in this area.

Từ khóa


Tài liệu tham khảo

10.1006/expr.1997.4229

Brindley PJ, 1987, The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response, Journal of Immunology, 139, 215, 10.4049/jimmunol.139.1.215

10.1016/S0169-4758(98)01323-4

10.1097/00001432-200012000-00014

10.1016/0169-4758(93)90138-6

DavisA(1993)Antischistosomal drugs and clinical practice. In:Human Schistosomiasis(eds P Jordan G Webbe & RF Sturrock) CAB International Wallingford UK pp. 367–404.

De VlasSJ(1996)Modelling humanSchistosoma mansoniinfection: the art of counting eggs in faeces. PhD Thesis Erasmus University Rotterdam.

10.1016/0169-4758(92)90144-Q

10.1017/S003118200006371X

10.1016/0169-4758(93)90132-Y

10.1017/s0031182096008207

10.1016/s0169-4758(97)01206-4

10.4269/ajtmh.1994.51.83

10.4269/ajtmh.1995.53.61

10.1006/expr.1997.4149

10.1128/CMR.13.2.207-222.2000

10.1016/0035-9203(87)90439-1

Gryseels B, 1994, Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal, Tropical and Geographical Medicine, 46, 209

10.4269/ajtmh.1997.56.511

Homeida MM, 1988, Efficacy and tolerance of praziquantel in patients with Schistosoma mansoni infection and Symmers’ fibrosis: a field study in the Sudan, American Journal of Tropical Medicine and Hygiene, 38, 496, 10.4269/ajtmh.1988.38.496

10.4269/ajtmh.1996.55.214

10.4269/ajtmh.1999.60.932

Kongs A, 1994, Epidemic schistosomiasis in the delta of the Senegal River Basin, Senegal: responses of the health care system, Annales de la Société belge de Médecine Tropicale, 74, 301

10.1016/0924-8579(94)90032-9

LawAM&KeltonWD(1991)Simulation Modelling and Analysis 2nd edn. McGraw‐Hill New York USA.

10.1016/S0035-9203(98)90971-3

10.1016/0035-9203(88)90282-9

10.1016/s0169-4758(98)01310-6

10.1016/0014-4894(86)90184-0

Simonsen PE, 1990, Intestinal schistosomiasis among children in a labour village of Wonji Sugar Estate, Ethiopia, East African Medical Journal, 67, 532

10.4269/ajtmh.1993.49.701

10.4269/ajtmh.1995.53.167

10.1086/517273

Taddese K, 1988, Comparison between the efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infections on a sugar estate in Ethiopia, Annals of Tropical Medicine and Parasitology, 82, 175, 10.1080/00034983.1988.11812225

Talla I, 1990, Outbreak of intestinal schistosomiasis in the Senegal River Basin, Annales de la Société belge de Médecine Tropicale, 70, 173

10.1016/0035-9203(92)90562-Q

10.1016/S0035-9203(01)90335-9

10.4269/ajtmh.1999.61.760

Vercruysse J, 1994, Studies on transmission and schistosome interactions in Senegal, Mali and Zambia, Tropical and Geographical Medicine, 46, 220

World Health Organization(1983)The Role of Chemotherapy in Schistosomiasis Control. WHO/Schisto/83.70. World Health Organization Geneva.

World Health Organization, 1985, The control of schistosomiasis. Report of the WHO Expert Committee, WHO Technical Report Series, 728, 1

World Health Organization, 1992, Praziquantel shows unexpected failure in recent schistosomiasis outbreak, TDR News, 41, 1

World Health Organization, 1993, Praziquantel in Senegal schistosomiasis outbreak, TDR News, 42, 10

World Health Organization, 1993, The control of schistosomiasis. Report of the WHO Expert Committee, WHO Technical Report Series, 830, 1

10.1093/infdis/151.6.1130